NCT02219152

Brief Summary

Bleeding during transbronchial ro endobronchial biopsy is rather a common complication. Mostly this is an insignificant bleeding, but in 3% of the biopsies there is a substantial amount of bleeding that requires a special treatment or follow up. The goal of this study is to examine whether submission of tranexamic acid during the biopsy could diminish the amount of bleeding.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Sep 2014

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 18, 2014

Completed
14 days until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

June 1, 2018

Status Verified

May 1, 2018

Enrollment Period

5.3 years

First QC Date

August 12, 2014

Last Update Submit

May 30, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • amount of bleeding

    amount of bleedibg that will be calculated on the basis of the difference between the amount of saline that will be injected at the bronchoscopy and the blood and fluid that will be collected in the suction tank.

    participants will be followed for the duration of hospital stay, an expected average of one day

Secondary Outcomes (1)

  • amount of erythrocytes

    participants will be followed for the duration of hospital stay, an expected average of one day

Study Arms (2)

tranexamic acid

EXPERIMENTAL

tranexamic acid will be administrated using the bronchoscope

Drug: tranexamic acid

saline

PLACEBO COMPARATOR

the saline will be administrated using an infusion during the biopsy.

Drug: saline

Interventions

tranexamic acid
salineDRUG
saline

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient that are candidates to endobronchial or transcronchial biopsy

You may not qualify if:

  • S/P MI or CVA or PE or DVT .
  • S/P thrombophilia.
  • Patients under coagulation therpay
  • Chronic Renal Failure
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah Medical Organization

Jerusalem, 91120, Israel

RECRUITING

MeSH Terms

Interventions

Tranexamic AcidSodium Chloride

Intervention Hierarchy (Ancestors)

Cyclohexanecarboxylic AcidsAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Neville Berkman, MD

    Hadassah Medical Organization

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Topical Instillation of Tranexamic Aacid in Bronchoscopy to Decrease Bleeding During Entobronchial & Transbronchial Biopsiy: a Prospective Double Blind Placebo Controlled Study

Study Record Dates

First Submitted

August 12, 2014

First Posted

August 18, 2014

Study Start

September 1, 2014

Primary Completion

January 1, 2020

Study Completion

December 1, 2020

Last Updated

June 1, 2018

Record last verified: 2018-05

Locations